Strain Specific Pathogenicity
Strain Specific Pathogenicity - Related Videos
02:12
Muscle Necrosis Assay in C. elegans Induced by a Pathogenic Aeromonas Strain
0 Views •
2026
Source: Chen, Y. et. al., Evaluating Virulence and Pathogenesis of Aeromonas Infection in a Caenorhabditis elegans Model. J. Vis. Exp. (2018)This video demonstrates a muscle necrosis assay in C. elegans (Caenorhabditis elegans) using pathogenic Aeromonas strains. By feeding green fluorescent protein (GFP)-expressing worms on Aeromonas-seeded plates, the assay models bacterial infection and reveals tissue damage through fluorescence imaging. The progressive loss of muscle structure and GFP...
02:25
Culturing and Isolating Capsule-Forming Pathogenic Bacterial Strains
0 Views •
2025
Source: Feltwell, T., et.al. Separating Bacteria by Capsule Amount Using a Discontinuous Density Gradient. J. Vis. Exp. (2019)This video demonstrates the preparation and characterization of bacterial strains with varying capsule production. Pathogenic strains carrying different mutations in capsule-related genes are cultured, grown in liquid media, and subjected to centrifugation to distinguish capsule phenotypes based on pellet density. Buffer treatment is used to wash and stabilize the cells...
03:45
A Bead-Based Multiplex Immunoassay to Identify Pathogen-Specific Antibodies in Saliva
0 Views •
2025
This video demonstrates a bead-based multiplex immunoassay technique to simultaneously detect antibodies for multiple environmental pathogens in human saliva. Fluorescent beads were coupled to antigens from different pathogens, which were captured using antibodies in the human saliva sample. Upon labeling the antibodies using a fluorescent reporter, the beads were analyzed using flow cytometry to assess the presence of different pathogen-specific antibodies in the saliva.
10:39
Single Cell Measurements of Vacuolar Rupture Caused by Intracellular Pathogens
0 Views •
Cited by 22 •
2013
We describe a method for tracking the endomembrane rupture elicited by the intracellular bacteria Shigella flexneri and Mycobacterium tuberculosis upon host cell invasion. Our assay makes use of CCF4, a host cytoplasmic FRET probe in live or fixed cells. This reporter is degraded by an enzyme activity present on the bacterial surface.
02:58
Measurement of Compressive Stress-Strain Response at Small-Strains
0 Views •
2025
This protocol presents the configuration of a compression test device capable of precisely measuring the mechanical properties of microstructures in the small-strain region, along with a systematic method for compression testing using this device. The proposed device can be used to analyze various microstructures and the mechanical behavior of polymer-based materials.
FAQs
Genomic differences can modify the presence, structure, or activity of virulence factors, which are microbial traits that contribute to disease. They may also influence toxin production, surface structures, immune evasion, or tissue colonization. As a result, closely related strains can interact with the same host in different ways and produce outcomes ranging from mild illness to severe disease.
Surface structures can affect how a microbe interacts with host tissues and immune defenses, while immune evasion can reduce the host’s ability to control infection. Differences in either feature may change persistence, tissue involvement, and disease severity. Examining these traits helps explain why strains from one species can produce distinct infection patterns in infected organisms.
A strain’s traits can determine whether it colonizes particular host tissues and how effectively it interacts with those environments. Variation in surface structures, virulence factors, or immune evasion may therefore influence which hosts are affected and which tissues become involved. This provides a biological explanation for different disease forms among related microbial strains.
Strain-level pathogenicity helps researchers distinguish microbial variants that may differ in disease-causing potential. In surveillance and outbreak investigation, recognizing these differences supports interpretation of why related strains are associated with different clinical outcomes or levels of concern. The information can contribute to risk assessment by connecting microbial traits with observed infection patterns.
Comparing strains can reveal which microbial traits are associated with mild, severe, or otherwise different forms of disease. This supports a more precise interpretation of clinical outcomes than treating all members of a species as biologically identical. Such comparisons are relevant to risk assessment because genetic variation may alter virulence, host interaction, and the consequences of infection.
Research on strain-level differences can identify microbial traits that influence host interaction, disease severity, and immune evasion. Those traits provide information relevant to developing vaccines or treatments that address important pathogenic features. The same knowledge can also clarify whether closely related strains may produce different outcomes, helping research programs account for variation within a microbial species.